Edwards Lifesciences Corporation Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Edwards Lifesciences Corporation stock issued during period, value, acquisitions for the quarter ending 2018-12-31 was $34.90M.
- Edwards Lifesciences Corporation stock issued during period, value, acquisitions for the quarter ending 2018-09-30 was $0.00.
- Edwards Lifesciences Corporation stock issued during period, value, acquisitions for the quarter ending 2018-06-30 was $34.90M.
- Edwards Lifesciences Corporation stock issued during period, value, acquisitions for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation stock issued during period, value, acquisitions for fiscal 2018 was $34.90M, a 86.90% decline from fiscal 2017.
- Edwards Lifesciences Corporation stock issued during period, value, acquisitions for fiscal 2017 was $266.50M.
- Edwards Lifesciences Corporation stock issued during period, value, acquisitions for fiscal 2016 was $0.00.
- Edwards Lifesciences Corporation stock issued during period, value, acquisitions for fiscal 2015 was $0.00.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2018-12-31 | $34.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $34.90M 10-K · filed 2021-02-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $34.90M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $34.90M 10-Q · filed 2019-10-25 | $34.90M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $0.00 10-Q · filed 2018-04-27 | $0.00 derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $266.50M 10-K · filed 2020-02-14 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | |
| 2017-03-31 | $266.50M 10-Q · filed 2018-04-27 | |
| 2016-12-31 | $0.00 10-K · filed 2018-02-16 | |
| 2015-12-31 | $0.00 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |